HAVCR2 and neoplasm: In the previous chapter, we mentioned that tumor-infiltrating pDCs start to express TIM-3, which upon interaction with HMBG1 interferes with the TLR-mediated immune responses of pDCs, and thus negatively influences their type I IFN secretion [118].